Immutep snaffles A$3.6M from French government for R&D
Biotech company Immutep Ltd (ASX:IMM) has received a R&D Tax Incentive of…
Immutep Limited (ASX:IMM)
About Immutep Limited
Key Information
IMM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 22/11/2024 | Results of Meeting | 136.15KB | 4.7K |
| 22/11/2024 | Immutep AGM 2024 - CEO's Presentation | 1.43MB | 401 |
| 22/11/2024 | Immutep AGM 2024 - Chairman's Address | 190.03KB | 1.1K |
| 18/11/2024 | Change in substantial holding | 91.09KB | 1.8K |
| 14/11/2024 | Price Sensitive PS Excellent Survival Data from INSIGHT-003 Trial in NSCLC | 299.39KB | 28K |
| 14/11/2024 | Price Sensitive PS Positive Data from Phase II Trial in Soft Tissue Sarcoma | 262.09KB | 1.2K |
| 14/11/2024 | Becoming a substantial holder | 606.6KB | 420 |
| 29/10/2024 | Price Sensitive PS Immutep Quarterly Activities Report and Appendix 4C | 1.02MB | 584 |